 Connection
Arnon Haran to Precursor Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications Arnon Haran has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.475 |
|
|
|
-
Gross Even Zohar N, Oanunu U, Gross Even-Zohar N, Aumann S, Vainstein V, Gural A, Gatt ME, Haran A, Nachmias B. Prognostic Factors, FLT-3 Mutations, and Treatment Outcomes with Pediatric-Inspired Protocols in Adolescent and Young Adults and Adult Patients with Acute Lymphoblastic Leukemia. Acta Haematol. 2025; 148(6):664-674.
Score: 0.173
-
Canaani J, Frisch A, Pollyea DA, Schwartz M, Aumann S, Ganzel C, Haran A, Even-Zohar NG, Shaulov A, Vainstein V, Moshe Y, Ofran Y, Wolach O, Nachmias B. Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia. Eur J Haematol. 2023 Sep; 111(3):365-372.
Score: 0.155
-
Aumann S, Shaulov A, Haran A, Gross Even-Zohar N, Vainstein V, Nachmias B. The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia. Int J Mol Sci. 2022 Sep 19; 23(18).
Score: 0.147
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|